MLLT3 and acute myeloid leukemia: The MLL-AF9 fusion gene was less commonly observed in patients with acute lymphocytic leukaemia (ALL), with myelodysplastic syndrome (MDS) and with therapy-related AML (t-AML) [88, 112].